- Product Details
Keywords
- abamectin 1.8 ec
- abamectin agrimec
- abamectin 95 tc
Quick Details
- ProName: abamectin 1.8 ec/abamectin agrimec/aba...
- CasNo: 71751-41-2
- Molecular Formula: C48H72O14;C47H70O14
- Appearance: white powder
- Application: insecticide
- DeliveryTime: 10-25Days
- PackAge: 25kgs/drum
- Port: SHANGHAI, CHINA
- ProductionCapacity: 500 Metric Ton/Year
- Purity: 95%TC 1.8%EC 3.6%EC 5.4%EC
- Storage: indoor
- Transportation: by truck,sea,air
- LimitNum: 100 Kilogram
Superiority
1 Inspection by SGS BV CIQ etc.
2 Payment guarantee by SINOSURE
3 Special door to door delivery is available, no need any license for customer.
1 active ingredient and formulation 2 quantity
3 packing details 4 price term FOB,CFR CIF+ destination port
For example: glyphosate 95%tc 20tons 25kgs/bag CIF Durban.
Details
Product name |
Abamectin(Avermectin) 95%TC 1.8%EC 3.6%EC 5.4%EC |
|||||||||||||||||||||||||||||||||||||||||||||||
General info |
Common name: Abamectin(Avermectin) Chemical name: B-995, N-Dimethylamino succinamic acid; Daminozide CAS No. : 1596-84-5 Molecular Formula: B1a C48H72O14; B1b C47H70O14 |
|||||||||||||||||||||||||||||||||||||||||||||||
Properties |
Appearance: Light brown liquid Molecular Formula: B1a C48H72O14; B1b C47H70O14 Molecular Weight: B1a 873.11; B1b 859.08 Solubility: In water: 0.51g/L @20℃; In organic solvent: Dichloromethane 50 - 100 g/L, isopropanol1 – 2 g/L, toluene0.5 - 1 g/L, n-hexane 0.1g/L@20℃ Density: 1.18 at 22℃ Melting Point: 150~155℃ Boiling Point: Not applicable Flash Point: Not applicable |
|||||||||||||||||||||||||||||||||||||||||||||||
Toxicity |
Acute Oral LD50 (rat): 416 mg/kg Acute Dermal LD50 (rat): 2,000-5,000 mg/kg (females); >5,000(males) Acute Inhalation LC50 (rat): >2.13 mg/L Eye Irritation (rabbit): Moderately irritating Dermal Irritation (rabbit): Slight irritating Dermal Sensitization (guinea pig): Not a skin sensitizer |
|||||||||||||||||||||||||||||||||||||||||||||||
Application |
Insecticide and acaricide with contact and stomach action. Has limited plant systemic activity, but exhibits translaminar movement. |
|||||||||||||||||||||||||||||||||||||||||||||||
Specifications |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Others |
|